nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—Alzheimer's disease—amyotrophic lateral sclerosis	0.799	1	CtDrD
Memantine—Condition aggravated—Riluzole—amyotrophic lateral sclerosis	0.00327	0.0307	CcSEcCtD
Memantine—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.00321	0.0855	CbGeAlD
Memantine—GRIN2B—nerve—amyotrophic lateral sclerosis	0.00284	0.0756	CbGeAlD
Memantine—Pneumonia aspiration—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0256	CcSEcCtD
Memantine—GRIN2A—nerve—amyotrophic lateral sclerosis	0.00248	0.0661	CbGeAlD
Memantine—GRIN1—hindbrain—amyotrophic lateral sclerosis	0.00223	0.0594	CbGeAlD
Memantine—GRIN2B—hindbrain—amyotrophic lateral sclerosis	0.00213	0.0566	CbGeAlD
Memantine—Cardiac murmur—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0181	CcSEcCtD
Memantine—GRIN2A—hindbrain—amyotrophic lateral sclerosis	0.00186	0.0495	CbGeAlD
Memantine—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0157	CcSEcCtD
Memantine—HTR3A—nerve—amyotrophic lateral sclerosis	0.00164	0.0438	CbGeAlD
Memantine—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.0016	0.015	CcSEcCtD
Memantine—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0132	CcSEcCtD
Memantine—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00138	0.0129	CcSEcCtD
Memantine—GRIN1—brainstem—amyotrophic lateral sclerosis	0.00128	0.034	CbGeAlD
Memantine—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0119	CcSEcCtD
Memantine—GRIN2B—brainstem—amyotrophic lateral sclerosis	0.00122	0.0325	CbGeAlD
Memantine—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.0012	0.0113	CcSEcCtD
Memantine—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0111	CcSEcCtD
Memantine—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0111	CcSEcCtD
Memantine—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0101	CcSEcCtD
Memantine—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00999	CcSEcCtD
Memantine—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00999	CcSEcCtD
Memantine—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00999	CcSEcCtD
Memantine—GRIN2A—brainstem—amyotrophic lateral sclerosis	0.00106	0.0284	CbGeAlD
Memantine—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00987	CcSEcCtD
Memantine—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00964	CcSEcCtD
Memantine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00952	CcSEcCtD
Memantine—DRD2—nerve—amyotrophic lateral sclerosis	0.00101	0.0268	CbGeAlD
Memantine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.000993	0.00931	CcSEcCtD
Memantine—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.000982	0.0092	CcSEcCtD
Memantine—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.000971	0.0091	CcSEcCtD
Memantine—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00093	0.00872	CcSEcCtD
Memantine—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00863	CcSEcCtD
Memantine—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000912	0.00855	CcSEcCtD
Memantine—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.000912	0.00855	CcSEcCtD
Memantine—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.000885	0.00829	CcSEcCtD
Memantine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.000876	0.00821	CcSEcCtD
Memantine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.000852	0.00798	CcSEcCtD
Memantine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.000844	0.00791	CcSEcCtD
Memantine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.000844	0.00791	CcSEcCtD
Memantine—Apathy—Riluzole—amyotrophic lateral sclerosis	0.000836	0.00784	CcSEcCtD
Memantine—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00777	CcSEcCtD
Memantine—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00777	CcSEcCtD
Memantine—Mania—Riluzole—amyotrophic lateral sclerosis	0.000821	0.0077	CcSEcCtD
Memantine—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.000807	0.00757	CcSEcCtD
Memantine—Stupor—Riluzole—amyotrophic lateral sclerosis	0.0008	0.0075	CcSEcCtD
Memantine—GRIN1—spinal cord—amyotrophic lateral sclerosis	0.000794	0.0212	CbGeAlD
Memantine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.000793	0.00744	CcSEcCtD
Memantine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.000793	0.00744	CcSEcCtD
Memantine—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.000767	0.00719	CcSEcCtD
Memantine—GRIN2B—spinal cord—amyotrophic lateral sclerosis	0.000758	0.0202	CbGeAlD
Memantine—Abscess—Riluzole—amyotrophic lateral sclerosis	0.000755	0.00708	CcSEcCtD
Memantine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.000754	0.0201	CbGeAlD
Memantine—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.000743	0.00697	CcSEcCtD
Memantine—GRIN2A—medulla oblongata—amyotrophic lateral sclerosis	0.000743	0.0198	CbGeAlD
Memantine—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000726	0.00681	CcSEcCtD
Memantine—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00072	0.00675	CcSEcCtD
Memantine—HTR3A—brainstem—amyotrophic lateral sclerosis	0.000706	0.0188	CbGeAlD
Memantine—GRIN3A—nervous system—amyotrophic lateral sclerosis	0.000706	0.0188	CbGeAlD
Memantine—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.000705	0.00661	CcSEcCtD
Memantine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.000694	0.00651	CcSEcCtD
Memantine—GRIN3A—central nervous system—amyotrophic lateral sclerosis	0.00068	0.0181	CbGeAlD
Memantine—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.000675	0.00633	CcSEcCtD
Memantine—GRIN1—nervous system—amyotrophic lateral sclerosis	0.000669	0.0178	CbGeAlD
Memantine—GRIN2A—spinal cord—amyotrophic lateral sclerosis	0.000662	0.0176	CbGeAlD
Memantine—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.000661	0.0062	CcSEcCtD
Memantine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.000657	0.00616	CcSEcCtD
Memantine—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.000657	0.00616	CcSEcCtD
Memantine—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.000652	0.00612	CcSEcCtD
Memantine—GRIN1—central nervous system—amyotrophic lateral sclerosis	0.000644	0.0172	CbGeAlD
Memantine—Gout—Riluzole—amyotrophic lateral sclerosis	0.00064	0.006	CcSEcCtD
Memantine—GRIN2B—nervous system—amyotrophic lateral sclerosis	0.000638	0.017	CbGeAlD
Memantine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.000636	0.00596	CcSEcCtD
Memantine—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.000631	0.00592	CcSEcCtD
Memantine—GRIN1—cerebellum—amyotrophic lateral sclerosis	0.00063	0.0168	CbGeAlD
Memantine—Cataract—Riluzole—amyotrophic lateral sclerosis	0.000627	0.00588	CcSEcCtD
Memantine—GRIN2B—central nervous system—amyotrophic lateral sclerosis	0.000615	0.0164	CbGeAlD
Memantine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.000612	0.00574	CcSEcCtD
Memantine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.000608	0.0057	CcSEcCtD
Memantine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.000608	0.0057	CcSEcCtD
Memantine—GRIN2B—cerebellum—amyotrophic lateral sclerosis	0.000601	0.016	CbGeAlD
Memantine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.000597	0.0056	CcSEcCtD
Memantine—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.000597	0.0056	CcSEcCtD
Memantine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.000583	0.00547	CcSEcCtD
Memantine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000577	0.00541	CcSEcCtD
Memantine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.000577	0.00541	CcSEcCtD
Memantine—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00057	0.00535	CcSEcCtD
Memantine—GRIN2A—nervous system—amyotrophic lateral sclerosis	0.000558	0.0149	CbGeAlD
Memantine—Coma—Riluzole—amyotrophic lateral sclerosis	0.000546	0.00512	CcSEcCtD
Memantine—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00054	0.00506	CcSEcCtD
Memantine—GRIN3A—brain—amyotrophic lateral sclerosis	0.000539	0.0144	CbGeAlD
Memantine—GRIN2A—central nervous system—amyotrophic lateral sclerosis	0.000537	0.0143	CbGeAlD
Memantine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.000532	0.00498	CcSEcCtD
Memantine—GRIN2A—cerebellum—amyotrophic lateral sclerosis	0.000525	0.014	CbGeAlD
Memantine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.000524	0.00491	CcSEcCtD
Memantine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00486	CcSEcCtD
Memantine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00486	CcSEcCtD
Memantine—GRIN1—brain—amyotrophic lateral sclerosis	0.000511	0.0136	CbGeAlD
Memantine—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000508	0.00476	CcSEcCtD
Memantine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.000503	0.00472	CcSEcCtD
Memantine—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.000498	0.00467	CcSEcCtD
Memantine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000498	0.00467	CcSEcCtD
Memantine—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.000496	0.00465	CcSEcCtD
Memantine—GRIN2B—brain—amyotrophic lateral sclerosis	0.000488	0.013	CbGeAlD
Memantine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.000485	0.00454	CcSEcCtD
Memantine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.000485	0.00454	CcSEcCtD
Memantine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000482	0.00452	CcSEcCtD
Memantine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000478	0.00448	CcSEcCtD
Memantine—Injury—Riluzole—amyotrophic lateral sclerosis	0.000472	0.00442	CcSEcCtD
Memantine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000468	0.00438	CcSEcCtD
Memantine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000461	0.00433	CcSEcCtD
Memantine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.000461	0.00433	CcSEcCtD
Memantine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.000458	0.00429	CcSEcCtD
Memantine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00045	0.00422	CcSEcCtD
Memantine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000446	0.00418	CcSEcCtD
Memantine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000444	0.00417	CcSEcCtD
Memantine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.000435	0.00408	CcSEcCtD
Memantine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000434	0.00406	CcSEcCtD
Memantine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000434	0.00406	CcSEcCtD
Memantine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000434	0.00406	CcSEcCtD
Memantine—DRD2—brainstem—amyotrophic lateral sclerosis	0.000432	0.0115	CbGeAlD
Memantine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00403	CcSEcCtD
Memantine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000427	0.004	CcSEcCtD
Memantine—GRIN2A—brain—amyotrophic lateral sclerosis	0.000426	0.0114	CbGeAlD
Memantine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000423	0.00397	CcSEcCtD
Memantine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000412	0.00387	CcSEcCtD
Memantine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.000412	0.00387	CcSEcCtD
Memantine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000411	0.00385	CcSEcCtD
Memantine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00382	CcSEcCtD
Memantine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000403	0.00378	CcSEcCtD
Memantine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0004	0.00375	CcSEcCtD
Memantine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000396	0.00371	CcSEcCtD
Memantine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000395	0.0037	CcSEcCtD
Memantine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00039	0.00366	CcSEcCtD
Memantine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000384	0.0036	CcSEcCtD
Memantine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000382	0.00358	CcSEcCtD
Memantine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000382	0.00358	CcSEcCtD
Memantine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000375	0.00351	CcSEcCtD
Memantine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000375	0.00351	CcSEcCtD
Memantine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000375	0.00351	CcSEcCtD
Memantine—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00037	0.00986	CbGeAlD
Memantine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000367	0.00344	CcSEcCtD
Memantine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000365	0.00342	CcSEcCtD
Memantine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00036	0.00338	CcSEcCtD
Memantine—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.000356	0.00949	CbGeAlD
Memantine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000356	0.00334	CcSEcCtD
Memantine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00035	0.00329	CcSEcCtD
Memantine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00035	0.00329	CcSEcCtD
Memantine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000346	0.00325	CcSEcCtD
Memantine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000345	0.00324	CcSEcCtD
Memantine—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000342	0.00911	CbGeAlD
Memantine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000341	0.0032	CcSEcCtD
Memantine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00318	CcSEcCtD
Memantine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000336	0.00315	CcSEcCtD
Memantine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00313	CcSEcCtD
Memantine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00313	CcSEcCtD
Memantine—Depression—Riluzole—amyotrophic lateral sclerosis	0.000333	0.00312	CcSEcCtD
Memantine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00309	CcSEcCtD
Memantine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000328	0.00307	CcSEcCtD
Memantine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000328	0.00307	CcSEcCtD
Memantine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000325	0.00304	CcSEcCtD
Memantine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000319	0.00299	CcSEcCtD
Memantine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000316	0.00296	CcSEcCtD
Memantine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000315	0.00295	CcSEcCtD
Memantine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000313	0.00294	CcSEcCtD
Memantine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000312	0.00292	CcSEcCtD
Memantine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000305	0.00286	CcSEcCtD
Memantine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000301	0.00283	CcSEcCtD
Memantine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000301	0.00282	CcSEcCtD
Memantine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0003	0.00281	CcSEcCtD
Memantine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0003	0.00281	CcSEcCtD
Memantine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000298	0.0028	CcSEcCtD
Memantine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000298	0.0028	CcSEcCtD
Memantine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000298	0.00279	CcSEcCtD
Memantine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000296	0.00278	CcSEcCtD
Memantine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000295	0.00277	CcSEcCtD
Memantine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000295	0.00276	CcSEcCtD
Memantine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000294	0.00276	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00029	0.00515	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.000285	0.00507	CbGpPWpGaD
Memantine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000284	0.00266	CcSEcCtD
Memantine—HTR3A—brain—amyotrophic lateral sclerosis	0.000283	0.00753	CbGeAlD
Memantine—SLC22A2—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.000283	0.00502	CbGpPWpGaD
Memantine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00028	0.00263	CcSEcCtD
Memantine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000278	0.00261	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.000278	0.00494	CbGpPWpGaD
Memantine—CYP2A6—brain—amyotrophic lateral sclerosis	0.000278	0.0074	CbGeAlD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000274	0.00487	CbGpPWpGaD
Memantine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000272	0.00255	CcSEcCtD
Memantine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000271	0.00254	CcSEcCtD
Memantine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00027	0.00253	CcSEcCtD
Memantine—Chills—Riluzole—amyotrophic lateral sclerosis	0.000269	0.00252	CcSEcCtD
Memantine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000268	0.00251	CcSEcCtD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000267	0.00474	CbGpPWpGaD
Memantine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000265	0.00248	CcSEcCtD
Memantine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000263	0.00246	CcSEcCtD
Memantine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000261	0.00245	CcSEcCtD
Memantine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000257	0.00241	CcSEcCtD
Memantine—Tension—Riluzole—amyotrophic lateral sclerosis	0.000256	0.0024	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000256	0.00455	CbGpPWpGaD
Memantine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000256	0.0024	CcSEcCtD
Memantine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000254	0.00238	CcSEcCtD
Memantine—GRIN1—Mecp2 and Associated Rett Syndrome—BDNF—amyotrophic lateral sclerosis	0.000253	0.00449	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000253	0.00449	CbGpPWpGaD
Memantine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000253	0.00237	CcSEcCtD
Memantine—SLC22A2—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.000252	0.00448	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.000247	0.00439	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000246	0.00438	CbGpPWpGaD
Memantine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000245	0.00229	CcSEcCtD
Memantine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000242	0.00227	CcSEcCtD
Memantine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000241	0.00226	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.000241	0.00428	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000241	0.00428	CbGpPWpGaD
Memantine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00024	0.00225	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000238	0.00423	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000236	0.00419	CbGpPWpGaD
Memantine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000235	0.00221	CcSEcCtD
Memantine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000235	0.0022	CcSEcCtD
Memantine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000234	0.0022	CcSEcCtD
Memantine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000234	0.00219	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000231	0.0041	CbGpPWpGaD
Memantine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000231	0.00216	CcSEcCtD
Memantine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000229	0.00215	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000229	0.00406	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000229	0.00406	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000229	0.00406	CbGpPWpGaD
Memantine—Cough—Riluzole—amyotrophic lateral sclerosis	0.000228	0.00214	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.000227	0.00403	CbGpPWpGaD
Memantine—DRD2—nervous system—amyotrophic lateral sclerosis	0.000226	0.00603	CbGeAlD
Memantine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000226	0.00212	CcSEcCtD
Memantine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000225	0.00211	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000223	0.00397	CbGpPWpGaD
Memantine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000222	0.00208	CcSEcCtD
Memantine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000222	0.00208	CcSEcCtD
Memantine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000222	0.00208	CcSEcCtD
Memantine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000222	0.00208	CcSEcCtD
Memantine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00022	0.00206	CcSEcCtD
Memantine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000218	0.00581	CbGeAlD
Memantine—GRIN2A—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000218	0.00387	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000218	0.00387	CbGpPWpGaD
Memantine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000217	0.00204	CcSEcCtD
Memantine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000215	0.00201	CcSEcCtD
Memantine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000213	0.002	CcSEcCtD
Memantine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000213	0.00567	CbGeAlD
Memantine—Infection—Riluzole—amyotrophic lateral sclerosis	0.000212	0.00198	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00021	0.00374	CbGpPWpGaD
Memantine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00021	0.00197	CcSEcCtD
Memantine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000209	0.00196	CcSEcCtD
Memantine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000209	0.00196	CcSEcCtD
Memantine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000208	0.00195	CcSEcCtD
Memantine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000207	0.00194	CcSEcCtD
Memantine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000206	0.00193	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000206	0.00366	CbGpPWpGaD
Memantine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000203	0.0019	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000201	0.00358	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000201	0.00357	CbGpPWpGaD
Memantine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000199	0.00187	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000196	0.00349	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000194	0.00182	CcSEcCtD
Memantine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000193	0.00181	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000192	0.00342	CbGpPWpGaD
Memantine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000191	0.00179	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00019	0.00338	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00019	0.00338	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00019	0.00338	CbGpPWpGaD
Memantine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00019	0.00178	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00019	0.00338	CbGpPWpGaD
Memantine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000189	0.00178	CcSEcCtD
Memantine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000188	0.00176	CcSEcCtD
Memantine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000185	0.00174	CcSEcCtD
Memantine—GRIN2B—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000185	0.00329	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000184	0.00172	CcSEcCtD
Memantine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000184	0.00172	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000183	0.00326	CbGpPWpGaD
Memantine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000183	0.00488	CbGeAlD
Memantine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000182	0.00171	CcSEcCtD
Memantine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000182	0.00171	CcSEcCtD
Memantine—GRIN2A—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000181	0.00321	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000179	0.00318	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000179	0.00318	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000179	0.00318	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000176	0.00314	CbGpPWpGaD
Memantine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000176	0.00469	CbGeAlD
Memantine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000176	0.00165	CcSEcCtD
Memantine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000174	0.00163	CcSEcCtD
Memantine—DRD2—brain—amyotrophic lateral sclerosis	0.000173	0.00461	CbGeAlD
Memantine—GRIN2B—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000172	0.00306	CbGpPWpGaD
Memantine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000169	0.00159	CcSEcCtD
Memantine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000168	0.00158	CcSEcCtD
Memantine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000168	0.00158	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000168	0.00298	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000167	0.00297	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000164	0.00291	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000161	0.00286	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000159	0.00283	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000158	0.0028	CbGpPWpGaD
Memantine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000157	0.00147	CcSEcCtD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—amyotrophic lateral sclerosis	0.000156	0.00278	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000156	0.00277	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000156	0.00277	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000154	0.00273	CbGpPWpGaD
Memantine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000153	0.00143	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000153	0.00272	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000152	0.0027	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000152	0.0027	CbGpPWpGaD
Memantine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000151	0.00141	CcSEcCtD
Memantine—GRIN2A—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000147	0.00262	CbGpPWpGaD
Memantine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000146	0.00137	CcSEcCtD
Memantine—GRIN1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000146	0.00259	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000142	0.00252	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000141	0.00251	CbGpPWpGaD
Memantine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000141	0.00132	CcSEcCtD
Memantine—GRIN1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000141	0.0025	CbGpPWpGaD
Memantine—CYP2B6—brain—amyotrophic lateral sclerosis	0.00014	0.00373	CbGeAlD
Memantine—GRIN1—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000139	0.00248	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000139	0.00247	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000137	0.00244	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000137	0.00244	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000137	0.00244	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000136	0.00242	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000136	0.00241	CbGpPWpGaD
Memantine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000135	0.00127	CcSEcCtD
Memantine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000134	0.00126	CcSEcCtD
Memantine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000134	0.00126	CcSEcCtD
Memantine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000133	0.00125	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000133	0.00237	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.00013	0.00231	CbGpPWpGaD
Memantine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000129	0.00229	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000129	0.00229	CbGpPWpGaD
Memantine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000127	0.00119	CcSEcCtD
Memantine—GRIN2B—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000125	0.00223	CbGpPWpGaD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.000123	0.00219	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000123	0.00219	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000122	0.00217	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000121	0.00215	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00012	0.00212	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00012	0.00212	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000118	0.0021	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000118	0.00209	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000117	0.00207	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000117	0.00207	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000117	0.00207	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000107	0.0019	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000107	0.00189	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000105	0.00187	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000104	0.00185	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000102	0.00182	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	9.88e-05	0.00176	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	9.85e-05	0.00175	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	9.72e-05	0.00173	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	9.54e-05	0.0017	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	9.08e-05	0.00161	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	8.72e-05	0.00155	CbGpPWpGaD
Memantine—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	8.65e-05	0.00154	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—PFN1—amyotrophic lateral sclerosis	8.62e-05	0.00153	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	8.54e-05	0.00152	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	8.48e-05	0.00151	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—PFN1—amyotrophic lateral sclerosis	8.4e-05	0.00149	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	8.26e-05	0.00147	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	8.2e-05	0.00146	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.14e-05	0.00145	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	8.11e-05	0.00144	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	8.11e-05	0.00144	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	7.73e-05	0.00137	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.72e-05	0.00137	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.72e-05	0.00137	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	7.57e-05	0.00134	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	7.31e-05	0.0013	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	7.23e-05	0.00128	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	6.97e-05	0.00124	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.88e-05	0.00122	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.8e-05	0.00121	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	6.8e-05	0.00121	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	6.68e-05	0.00119	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	6.62e-05	0.00118	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	6.58e-05	0.00117	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	6.57e-05	0.00117	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	6.29e-05	0.00112	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	6.26e-05	0.00111	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	6.23e-05	0.00111	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	6.21e-05	0.0011	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	6.21e-05	0.0011	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.15e-05	0.00109	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	6.15e-05	0.00109	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	6.1e-05	0.00108	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	6.1e-05	0.00108	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	6.02e-05	0.00107	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	5.91e-05	0.00105	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	5.86e-05	0.00104	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	5.81e-05	0.00103	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	5.54e-05	0.000984	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	5.44e-05	0.000966	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	5.3e-05	0.000942	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	5.24e-05	0.000932	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	5.21e-05	0.000927	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	5.15e-05	0.000915	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	5.11e-05	0.000909	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	5.02e-05	0.000892	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	5e-05	0.000889	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	4.92e-05	0.000874	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.74e-05	0.000842	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.51e-05	0.000802	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.33e-05	0.00077	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	4.17e-05	0.000742	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.03e-05	0.000716	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	3.94e-05	0.000701	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.93e-05	0.000698	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.83e-05	0.000681	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	3.81e-05	0.000677	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.79e-05	0.000673	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.77e-05	0.00067	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.77e-05	0.00067	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.64e-05	0.000647	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.59e-05	0.000639	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.46e-05	0.000615	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.46e-05	0.000615	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.45e-05	0.000613	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.34e-05	0.000594	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.34e-05	0.000594	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.2e-05	0.000569	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.16e-05	0.000562	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.01e-05	0.000535	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.98e-05	0.000529	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.94e-05	0.000523	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.79e-05	0.000496	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.79e-05	0.000496	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.77e-05	0.000492	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.75e-05	0.000489	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	2.75e-05	0.000488	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.72e-05	0.000484	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.71e-05	0.000482	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.59e-05	0.000461	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MMP9—amyotrophic lateral sclerosis	2.59e-05	0.00046	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.55e-05	0.000454	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MMP9—amyotrophic lateral sclerosis	2.53e-05	0.000449	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	2.5e-05	0.000445	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.37e-05	0.000422	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.33e-05	0.000413	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.27e-05	0.000403	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.23e-05	0.000397	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.18e-05	0.000388	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.15e-05	0.000383	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.11e-05	0.000375	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.11e-05	0.000375	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.06e-05	0.000367	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	2.02e-05	0.000359	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.97e-05	0.00035	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	1.95e-05	0.000347	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.93e-05	0.000343	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.91e-05	0.000339	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.9e-05	0.000337	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	1.85e-05	0.000329	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP9—amyotrophic lateral sclerosis	1.8e-05	0.00032	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.79e-05	0.000319	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	1.75e-05	0.000311	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.69e-05	0.0003	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.66e-05	0.000296	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.66e-05	0.000295	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.62e-05	0.000288	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.56e-05	0.000278	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.53e-05	0.000272	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.52e-05	0.000271	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.52e-05	0.000271	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.44e-05	0.000255	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.43e-05	0.000255	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.41e-05	0.000251	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.36e-05	0.000241	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.32e-05	0.000234	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.18e-05	0.00021	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.17e-05	0.000208	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.16e-05	0.000206	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.16e-05	0.000205	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.15e-05	0.000205	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.07e-05	0.00019	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.71e-06	0.000173	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.65e-06	0.000172	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.4e-06	0.000167	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	8.76e-06	0.000156	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.53e-06	0.000152	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.41e-06	0.000149	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.99e-06	0.000142	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.93e-06	0.000141	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.73e-06	0.000137	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.72e-06	0.000137	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.44e-06	0.000132	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.09e-06	0.000126	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.09e-06	0.000126	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	6.36e-06	0.000113	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.23e-06	0.000111	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.07e-06	0.000108	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	5.84e-06	0.000104	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.72e-06	0.000102	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.7e-06	0.000101	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.48e-06	9.73e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.04e-06	8.96e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	4.71e-06	8.37e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.71e-06	8.37e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.69e-06	8.34e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.36e-06	7.74e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.33e-06	7.69e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4e-06	7.11e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.88e-06	6.89e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.56e-06	6.33e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.23e-06	5.74e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.98e-06	5.3e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.82e-06	5.01e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.53e-06	4.5e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.44e-06	4.33e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.91e-06	3.4e-05	CbGpPWpGaD
